Richard D. Levere

1.8k total citations
54 papers, 1.5k citations indexed

About

Richard D. Levere is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Cell Biology. According to data from OpenAlex, Richard D. Levere has authored 54 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 19 papers in Pediatrics, Perinatology and Child Health and 11 papers in Cell Biology. Recurrent topics in Richard D. Levere's work include Heme Oxygenase-1 and Carbon Monoxide (27 papers), Neonatal Health and Biochemistry (17 papers) and Porphyrin Metabolism and Disorders (16 papers). Richard D. Levere is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (27 papers), Neonatal Health and Biochemistry (17 papers) and Porphyrin Metabolism and Disorders (16 papers). Richard D. Levere collaborates with scholars based in United States, Japan and Austria. Richard D. Levere's co-authors include Nader G. Abraham, Michal L. Schwartzman, Attallah Kappas, J. D. Lutton, S. Granick, Bruno Escalante, David Sacerdoti, John C. McGiff, Pavel Martásek and Alvin I. Goodman and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Richard D. Levere

53 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard D. Levere United States 23 875 353 286 188 186 54 1.5k
Janice R. Okita United States 22 399 0.5× 149 0.4× 228 0.8× 110 0.6× 129 0.7× 33 1.7k
Rajender K. Chawla United States 21 540 0.6× 72 0.2× 231 0.8× 104 0.6× 237 1.3× 47 1.5k
Martin Kömhoff Germany 25 730 0.8× 113 0.3× 429 1.5× 182 1.0× 168 0.9× 55 2.0k
B. Levin United Kingdom 22 531 0.6× 201 0.6× 199 0.7× 161 0.9× 249 1.3× 49 1.5k
Christiane Viedt Germany 19 567 0.6× 219 0.6× 84 0.3× 317 1.7× 287 1.5× 22 1.9k
L B Safier United States 15 301 0.3× 53 0.2× 175 0.6× 117 0.6× 276 1.5× 25 1.7k
Masayuki Tanemoto Japan 18 408 0.5× 425 1.2× 191 0.7× 376 2.0× 101 0.5× 44 1.8k
J. P. Farriaux France 24 682 0.8× 204 0.6× 95 0.3× 124 0.7× 392 2.1× 90 1.7k
Detlef Lang Germany 21 462 0.5× 198 0.6× 59 0.2× 56 0.3× 87 0.5× 40 1.5k
G Balla United States 6 1.2k 1.3× 438 1.2× 56 0.2× 23 0.1× 153 0.8× 7 1.6k

Countries citing papers authored by Richard D. Levere

Since Specialization
Citations

This map shows the geographic impact of Richard D. Levere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Levere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Levere more than expected).

Fields of papers citing papers by Richard D. Levere

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Levere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Levere. The network helps show where Richard D. Levere may publish in the future.

Co-authorship network of co-authors of Richard D. Levere

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Levere. A scholar is included among the top collaborators of Richard D. Levere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Levere. Richard D. Levere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lutton, J. D., Nader G. Abraham, George S. Drummond, Richard D. Levere, & Attallah Kappas. (1997). Zinc porphyrins: Potent inhibitors of hematopoieses in animal and human bone marrow. Proceedings of the National Academy of Sciences. 94(4). 1432–1436. 50 indexed citations
2.
Stoltz, Robert A., Michal L. Schwartzman, Michael W. Dunn, et al.. (1995). Modulation of Corneal Heme Oxygenase Expression by Oxidative Stress Agents. Journal of Ocular Pharmacology and Therapeutics. 11(3). 455–468. 27 indexed citations
3.
Abraham, Nader G., et al.. (1995). Differential heme oxygenase induction by stannous and stannic ions in the heart. Journal of Cellular Biochemistry. 57(3). 409–414. 16 indexed citations
4.
Schwartzman, Michal L., et al.. (1994). Localization of erythropoietin mRNA in the rat kidney by polymerase chain reaction. Journal of Cellular Biochemistry. 54(2). 239–246. 11 indexed citations
5.
Lavrovsky, Yan, et al.. (1994). Characterization of a 142-bp fragment of the murine c-fos oncogene promoter upstream of the SIF-binding element. Gene. 142(2). 285–290. 8 indexed citations
6.
Lutton, J. D., Miki Nishimura, Richard D. Levere, et al.. (1993). Coexpression of erythropoietin and heme oxygenase genes in Hep3B cells. Hepatology. 17(5). 861–868. 4 indexed citations
7.
Lutton, J. D., et al.. (1993). Synergistic effect of heme and IL‐1 on hematopoietic stromal regeneration after radiation. American Journal of Hematology. 44(3). 172–178. 9 indexed citations
8.
Lutton, J. D., J. L. Chertkov, Richard D. Levere, & Nader G. Abraham. (1991). Comparative Effect of Heme Analogues on Hematopoiesis in Lymphoproliferative Disorders. Leukemia & lymphoma. 5(2-3). 179–185. 9 indexed citations
9.
Lutton, J. D., et al.. (1988). Inhibition of Human Adult and Fetal Heme Oxygenase by New Synthetic Heme Analogues. The American Journal of the Medical Sciences. 296(3). 180–186. 23 indexed citations
10.
Abraham, Nader G., António Pinto, Richard D. Levere, & Kevin Mullane. (1987). Identification of heme oxygenase and cytochrome P-450 in the rabbit heart*. Journal of Molecular and Cellular Cardiology. 19(1). 73–81. 35 indexed citations
11.
Abraham, Nader G., Richard D. Levere, & Michael L. Freedman. (1985). Effect of age on rat liver heme and drug metabolism. Experimental Gerontology. 20(5). 277–284. 21 indexed citations
12.
Moqattash, S., J. D. Lutton, Jen Wei Chiao, & Richard D. Levere. (1985). Abolition of L1210 clonogeneticy and G1 arrest by retinoic acid and 1,25-dihydroxyvitamin D3. Cancer Letters. 27(2). 125–134. 6 indexed citations
13.
Lutton, J. D., et al.. (1984). Inhibition of Erythropoiesis in Chronic Renal Failure: The Role of Parathyroid Hormone. American Journal of Kidney Diseases. 3(5). 380–384. 6 indexed citations
14.
Pindyck, Johanna, Michael W. Mosesson, M. Waheed Roomi, & Richard D. Levere. (1975). Steroid effects on fibrinogen synthesis by cultured embryonic chicken hepatocytes. Biochemical Medicine. 12(1). 22–31. 18 indexed citations
15.
Josephson, Alan S., et al.. (1972). Porphyrin Synthesis by Cultured Lymphocytes. Blood. 39(4). 568–574. 3 indexed citations
16.
Mizoguchi, Hideaki & Richard D. Levere. (1971). ENHANCEMENT OF HEME AND GLOBIN SYNTHESIS IN CULTURED HUMAN MARROW BY CERTAIN 5ß-H STEROID METABOLITES. The Journal of Experimental Medicine. 134(6). 1501–1512. 37 indexed citations
17.
Gordon, Albert S., Esmail D. Zanjani, Richard D. Levere, & Attallah Kappas. (1970). Stimulation of Mammalian Erythropoiesis by 5β-H Steroid Metabolites. Proceedings of the National Academy of Sciences. 65(4). 919–924. 65 indexed citations
18.
Levere, Richard D.. (1966). Stilbestrol-Induced Porphyria: Increase in Hepatic δ-Aminolevulinic Acid Synthetase. Blood. 28(4). 569–572. 31 indexed citations
19.
Levere, Richard D., et al.. (1963). Metabolism of Heterogenic Hemoglobins. Blood. 22(3). 334–341. 10 indexed citations
20.
Lichtman, Herbert C., et al.. (1957). Treatment of Symptomatic Hemolytic Anemia with Prednisone. New England Journal of Medicine. 257(14). 631–637. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026